BELLUS Health's activity chart (see below) currently has 27 price targets and 29 ratings on display.
Analysts' price targets on this stock were met 60.07% of the time, taking 244.31 days on average.
Most recent stock forecast was given by from TRUIST on 15-May-2023. First documented stock forecast 30-Sep-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-May-2023
$14.75
$14.75
3 years 6 months 6 days ago
(15-May-2023)
4/7 (57.14%)
$0.28 (1.94%)
151
Buy Since 30-Sep-2019
$14.75
3 years 7 months 2 days ago
(19-Apr-2023)
1/2 (50%)
$0.31 (2.15%)
68
Buy Since 18-Nov-2020
$14.75
3 years 7 months 3 days ago
(18-Apr-2023)
2/2 (100%)
$0.31 (2.15%)
349
Buy Since 13-Dec-2021
$14.75
$15
3 years 7 months 3 days ago
(18-Apr-2023)
1/2 (50%)
$0.31 (2.15%)
69
Buy Since 26-Jun-2020
$20
$20
3 years 7 months 30 days ago
(22-Mar-2023)
2/6 (33.33%)
$12.23 (157.40%)
480
What is BLU (BELLUS Health) average time for price targets to be met?
Which analyst most recently updated their price target on BLU (BELLUS Health)?
Which analyst has the most public recommendations on BLU (BELLUS Health)?
Which analyst is the currently most bullish on BLU (BELLUS Health)?
Which analyst is the currently most reserved on BLU (BELLUS Health)?